Evidence map›Paper›PMID 35972651›Full record

ArticleDrug safety2022

Impact of Vaccine Hesitancy on Onset, Severity and Type of Self-reported Adverse Events: A French Cross-Sectional Survey.

Charles Khouri, Ayoub Larabi, Pierre Verger, Fatima Gauna, Jean-Luc Cracowski, Jeremy Ward

Abstract read
In one paragraph

Article in Drug safety, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Charles KhouriPharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France. CKhouri@chu-grenoble.fr.ORCID http://orcid.org/0000-0002-8427-8573
Ayoub LarabiPharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.
Pierre VergerVITROME (Aix Marseille Université, IRD, AP-HM, SSA), Marseille, France.
Fatima GaunaObservatoire régional de la santé PACA (ORS Paca), Aix-Marseille Université, Marseille, France.
Jean-Luc Cracowski *Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.
Jeremy Ward *VITROME (Aix Marseille Université, IRD, AP-HM, SSA), Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLittle is known about the impact of mandatory vaccination on people who are reluctant to be vaccinated, despite the potential importance in terms of public health policy.

objectiveWe aimed to explore the relationship between vaccine hesitancy and onset, severity and characteristics of self-reported adverse events.

methodsWe used a cross-sectional online survey conducted in 2021 among a representative sample of the French population aged 18 years and older (n = 1593). All reported adverse events were analyzed and categorized by trained experts in drug safety and pharmacovigilance. Multivariate binomial regressions on the onset of self-reported adverse events, vaccine hesitancy categories and predefined responders' characteristics were performed.

resultsOverall, 590 (37.0%) participants reported at least one adverse event, with 121 (20.5%) considered it to be severe. Proportions of reported adverse events, ranging from 18% (in non-reluctant responders) to 65% (in very reluctant responders), and their severity, ranging from 5% (non-reluctant responders) to 41% (very reluctant responders), depended highly on attitudes toward vaccination. The adverse events profile remained similar between groups. In the multivariate regression model, beyond attitude toward vaccination, younger age and female gender were significantly associated with higher reporting of vaccine adverse events.

conclusionsOur results suggest that vaccine hesitancy could be a major driver of patient-reported vaccine-related adverse events and their perceived severity. In this context, vaccinators must pay special attention to reluctant patients and inform them on the possible nocebo nature of these adverse events so as to prevent them.

Indexed as

Vaccination HesitancyVaccinesCross-Sectional StudiesFemaleHumansSelf ReportVaccinationVaccines

Identifiers

PMID35972651
PMCPMC9379877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.